| JBIO Market Cap History Table | ||||||||||||||
Below is a table of the JBIO market cap history going back to 4/24/2025:
Also see: JBIO Shares Outstanding History and JBIO YTD Return |
As of 8/3/2026 Jade Biosciences has a market cap of 1.22 billion. Investors often follow the JBIO market cap history to compare the size of the company over time.
This page shows JBIO market capitalization trends over time, with 6 market cap datapoints presented, dating back to 4/24/2025.

| JBIO Market Cap History Table | ||||||||||||||
Below is a table of the JBIO market cap history going back to 4/24/2025:
Also see: JBIO Shares Outstanding History and JBIO YTD Return |
| JBIO Market Cap History Chart | ||||||||||||||||||
JBIO Historical Market Cap: +753.48% CAGR
Mouse over chart for data details
| ||||||||||||||||||
| JBIO Stock Price Chart |
| About Jade Biosciences Inc. |
| Aerovate Therapeutics Inc. is a clinical-stage biopharmaceutical company. Co. is focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, its dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension (PAH), a devastating disease impacting approximately 70,000 people in the U.S. and Europe. Oral imatinib also demonstrated statistically significant improvement on the primary endpoint, six-minute walk distance, and multiple secondary hemodynamic endpoints in PAH patients. We show 6 historical shares outstanding datapoints in our JBIO shares outstanding history coverage, used to compute JBIO market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing JBIO market cap history over the course of time is important for investors interested in comparing JBIO's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of JBIO versus a peer is one thing; comparing JBIO market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like JBIO can fluctuate over the course of history. With this page we aim to empower investors researching JBIO by allowing them to research the JBIO market cap history. |
| JBIO Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| JBIO Share Performance |
| Market Cap Peers |
| Jade Biosciences (JBIO) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
JNCE Market Cap History JNJ Market Cap History JNP Market Cap History JSPR Market Cap History JUNS Market Cap History KA Market Cap History KALA Market Cap History KALV Market Cap History KDMN Market Cap History KDNY Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.